Fresh Tracks Therapeutics (FRTX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Fresh Tracks Therapeutics, Inc. stockholders convened for a crucial vote on the company’s future, deciding whether to approve its liquidation and dissolution. While the proposal to adjourn the meeting, if needed, to gather more votes passed effortlessly, the more consequential decision on liquidation did not secure the necessary majority from outstanding shares. Despite a majority present voting for it, the lack of overall majority support means the company won’t proceed with the dissolution as proposed.
For further insights into FRTX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue